Many scientists and advocates are hard at work advancing the study of Alzheimer's disease. The Alzheimer's Association, pharmaceutical industry, universities and our federal government have gained a detailed understanding of the basic disease progress at work in the Alzheimer's brain. A strategy to delay the onset of Alzheimer's by five years could halve the number of affected individuals over the next 50 years.








